T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.88% |
| 2 | Consumer Discretionary | 14.86% |
| 3 | Financials | 14.2% |
| 4 | Technology | 12.51% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Whirlpool
WHR
$2.79B
| $127M | 0.03% |
764,650
-101,521
| -12% | -$17.9M |
|
502
Valero Energy
VLO
$98.7B
| $127M | 0.03% |
2,497,960
-56,489
| -2% | -$3.2M |
|
503
ESCO Technologies
ESE
$7.79B
| $127M | 0.03% |
3,183,060
+106,840
| +3% | +$4.19M |
|
|
CTRA
504
DELISTED
Coterra Energy
CTRA
| $127M | 0.03% |
4,925,820
+3,835,830
| +352% | +$92M |
|
505
Omnicom Group
OMC
$24.2B
| $127M | 0.03% |
1,554,336
+52,768
| +4% | +$4.39M |
|
506
NorthWestern Energy
NWE
$4.4B
| $126M | 0.03% |
2,005,467
-39,458
| -2% | -$2.34M |
|
|
EE
507
DELISTED
El Paso Electric Company
EE
| $126M | 0.03% |
2,671,231
-567,160
| -18% | -$25.6M |
|
508
Papa John's
PZZA
$804M
| $125M | 0.03% |
1,837,541
+578,741
| +46% | +$35.3M |
|
509
Assured Guaranty
AGO
$3.35B
| $125M | 0.03% |
4,924,134
-4,352
| -0.1% | -$112K |
|
510
Ambev
ABEV
$43.8B
| $125M | 0.03% |
21,084,050
+13,562,150
| +180% | +$72.8M |
|
511
FMC
FMC
$1.27B
| $123M | 0.03% |
3,073,881
+576,858
| +23% | +$22.6M |
|
512
Exelixis
EXEL
$12.5B
| $121M | 0.03% |
15,526,930
-9,437,660
| -38% | -$54.4M |
|
513
Infosys
INFY
$50.3B
| $121M | 0.03% |
13,506,496
+76,970
| +0.6% | +$720K |
|
514
Service Corp International
SCI
$11.3B
| $120M | 0.03% |
4,440,985
+3,002,361
| +209% | +$79.2M |
|
|
EQC
515
DELISTED
Equity Commonwealth
EQC
| $120M | 0.03% |
4,117,270
+265,717
| +7% | +$7.55M |
|
516
Cameco
CCJ
$42.6B
| $120M | 0.03% |
10,926,480
+682,000
| +7% | +$8.09M |
|
517
Goldman Sachs
GS
$304B
| $120M | 0.03% |
806,395
-221,284
| -22% | -$34.5M |
|
518
Clearwater Paper
CLW
$354M
| $120M | 0.03% |
1,828,130
-35,480
| -2% | -$2.07M |
|
|
HOUS
519
DELISTED
Anywhere Real Estate
HOUS
| $119M | 0.03% |
4,102,515
+3,001,993
| +273% | +$98.8M |
|
520
Lockheed Martin
LMT
$138B
| $119M | 0.03% |
479,389
+3,300
| +0.7% | +$778K |
|
521
Marvell Technology
MRVL
$199B
| $119M | 0.03% |
12,478,165
-1,884,357
| -13% | -$18.8M |
|
|
PDCE
522
DELISTED
PDC Energy, Inc.
PDCE
| $117M | 0.02% |
2,038,301
-193,471
| -9% | -$11.5M |
|
523
Prothena Corp
PRTA
$466M
| $117M | 0.02% |
3,338,383
+10,400
| +0.3% | +$453K |
|
524
Etsy
ETSY
$7.4B
| $116M | 0.02% |
12,109,402
+1,778,841
| +17% | +$15.9M |
|
525
Glacier Bancorp
GBCI
$6.48B
| $116M | 0.02% |
4,351,731
-610,940
| -12% | -$15.9M |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.